We don't know whether the most recent response to this request contains information or not – if you are R Whyte please sign in and let everyone know.

Vanlafaxine - Bioavailability studies

R Whyte made this Official Information request to Pharmaceutical Management Agency

This request has an unknown status. We're waiting for R Whyte to read a recent response and update the status.

From: R Whyte

Dear Pharmaceutical Management Agency,

This is a official information request for any and all bioavailability and pharmacodynamic studies that were submitted to or are held by Pharmac for both the current and previous formulations of venlafaxine (Enlax XR, Effexor XR and Arrow Venlafaxine XR).

Yours faithfully,
R Whyte

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Dear R Whyte

 

This email is to acknowledge that your request for information under the
Official Information Act (1982) has been received and is currently being
worked on. We will have a reply to you as soon as possible and no later
than the due date of 17 April 2018.

 

 

Kind regards

Dean Zeng

PHARMAC

 

show quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment Request for Venlafaxine Bioavailability and Pharmacodynamics Data.pdf
154K Download View as HTML


Dear R Whyte

 

Please see attached the response to your OIA request.

 

 

Kind regards

Dean Zeng

PHARMAC

 

show quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2019 06 release of further information to Mr Whyte.pdf
70K Download View as HTML

Attachment 2019 06 10 Document for release with watermark.pdf
2.0M Download View as HTML


Dear Mt Whyte

Please find attached a response to you and the information requested.

 

Kind regards

Donna Jennings

PHARMAC

 

 

 

show quoted sections

Link to this

We don't know whether the most recent response to this request contains information or not – if you are R Whyte please sign in and let everyone know.

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: